Showing posts with label pharmaceutical. Show all posts
Showing posts with label pharmaceutical. Show all posts

Thursday, 6 February 2014

Anti-Hypertensive Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Pharmaceuticals copy
Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Also referred to as arterial hypertension or high blood pressure in generic terms, the condition is measured in terms of systolic and diastolic pressure. At rest blood pressure level is in the range of 120-140 mm Hg systolic and 60-90mm Hg diastolic. Hypertension arises when it is persistently at or above the 140/90mm Hg level. Primary hypertension, a condition with no underlying medical cause is highly prevalent than secondary hypertension which is caused by other conditions such as kidney, heart, endocrine or arterial disorders. Changing lifestyle habits such as diet, smoking and exercising are the major cause of hypertension. Hypertension is one of the most powerful risk factors for cardiovascular morbidity and mortality.
Based on their therapeutic class, the anti-hypertensive drugs market is classified into diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, beta blockers, alpha blockers, vasodilators and renin inhibitors. These drugs find their therapeutic use as single drug administration or in fixed dose combinations. Diuretics are the first line of treatment recommended by the physicians for most patients. However, the drug preference depends on the patient’s medical history and current conditions. For instance, a hypertensive patient with diabetes may be recommended an ACE inhibitor as a first line treatment.
Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive dugs is sustainable and will increase with increase in the number of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the global sales value of more than USD 40 billion, according to the World Preview 2018 report by Evaluate Pharma.
This market however, will be volatile due to patent expiries of blockbuster drugs, generic erosion, and launch of novel molecules. For example, the patent expiration of blockbuster drugs such as Diovan, Revatio, Avapro, Exforge and BIopress has impacted the global anti-hypertensive market with the entry of generics. On the other hand, the demand for fixed dose combinations is certain to rise, backed by the increase in number of patients. Factors such as aging population and lifestyle modifications will lead to an increase in the global incidence rate of hypertension.
Some of the key players contributing to the global anti-hypertensive drugs market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Takeda Pharmaceutical Company Limited.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
download-pdf (3)
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted by at No comments:
Labels: , , ,

Tuesday, 4 February 2014

Lyophilization Market - Global Industry Analysis

Transparency Market Research
Lyophilization also called as freeze drying is a process of dehydration of samples, commonly used to preserve perishable substances. In pharmaceutical industries, it is used to concentrate and stabilize products into powder form. The process consists of four stages- lyophilization pretreatment, freezing the compound, primary drying process, secondary drying. 

Pretreating the products includes concentrating the product and formulation to increase the surface area. Once the product is pretreated, it is frozen using methanol or liquid nitrogen. At this stage, the compound is cooled below its triple point which is the lowest temperature at which the vapor, liquid and solid state co-exist. In the next stage of primary drying, the pressure is reduced so that water in the compound sublimates. In the last stage, the unfrozen water molecules are removed by increasing the temperature to near 0 degrees and lowering pressure for desorption.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/lyophilization-pharmaceuticals-market.html

Lyophilization is an effective preservation process and stabilization of compounds such as proteins, peptides, vaccines, blood fractions, enzymes, microbes, nutraceuticals and other biopharmaceutical products. They help in extending the shelf life while maintaining the functionality and integrity of the biomolecules. Due to reduction of storage space and weight, they also make the handling easier and avoid the need of cold storage.

Lyophilization market can be segmented based on product type as follows:
  • Lyophilization units
  • Manifold freeze dryer
  • Rotary freeze dryer
  • Tray style freeze dryer
  • Lyophilization services

The lyophilization market will be driven by its wide scope of application, the advances in the pharmaceutical industry such as new drug discovery and technological advances in the lyophilization methods such as computer controlled process and automation in loading and unloading by robotics. These augmentations will make the overall process easier and will help in expanding the scope of application. The lyophilization instruments are expensive and high electricity consumption unit. Apart from these factors the process time for lyophilization is also long. But considering the merits, the restraints do not drastically affect the market growth.

Some of the key players in the lyophilization units market are ABB Ltd., W.L. Gore & Associates, Inc. and GEA Niro while Lyophilization Technology, Inc., GenScript, Inc. Irvine Pharmaceutical Services are some of the pyophilization services providers.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. 

Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World 

This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments



Browse More Reports on Pharmaceutical Market:
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
Transparency Market Research

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Researche Report:-
http://www.tmrblog.com/
http://marketingfirmblog.wordpress.com/
http://marketingresearchreport.blogspot.com
Posted by at No comments:
Labels: , , , ,
Location: New York, NY, USA

Anti-Hypertensive Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Transparency Market Research
Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Also referred to as arterial hypertension or high blood pressure in generic terms, the condition is measured in terms of systolic and diastolic pressure. At rest blood pressure level is in the range of 120-140 mm Hg systolic and 60-90mm Hg diastolic. 

Hypertension arises when it is persistently at or above the 140/90mm Hg level. Primary hypertension, a condition with no underlying medical cause is highly prevalent than secondary hypertension which is caused by other conditions such as kidney, heart, endocrine or arterial disorders. Changing lifestyle habits such as diet, smoking and exercising are the major cause of hypertension. Hypertension is one of the most powerful risk factors for cardiovascular morbidity and mortality.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/anti-hypertensive-drugs.html

Based on their therapeutic class, the anti-hypertensive drugs market is classified into diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, beta blockers, alpha blockers, vasodilators and renin inhibitors. These drugs find their therapeutic use as single drug administration or in fixed dose combinations. Diuretics are the first line of treatment recommended by the physicians for most patients. However, the drug preference depends on the patient’s medical history and current conditions. For instance, a hypertensive patient with diabetes may be recommended an ACE inhibitor as a first line treatment. 

Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive dugs is sustainable and will increase with increase in the number of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the global sales value of more than USD 40 billion, according to the World Preview 2018 report by Evaluate Pharma.

This market however, will be volatile due to patent expiries of blockbuster drugs, generic erosion, and launch of novel molecules. For example, the patent expiration of blockbuster drugs such as Diovan, Revatio, Avapro, Exforge and BIopress has impacted the global anti-hypertensive market with the entry of generics. On the other hand, the demand for fixed dose combinations is certain to rise, backed by the increase in number of patients. Factors such as aging population and lifestyle modifications will lead to an increase in the global incidence rate of hypertension. 

Some of the key players contributing to the global anti-hypertensive drugs market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Takeda Pharmaceutical Company Limited.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. 

Geographies analyzed under this research report include

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players.

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
  
About Us:-
Transparency Market Research

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Researche Report:-
http://www.tmrblog.com/
http://marketingfirmblog.wordpress.com/

http://marketingresearchreport.blogspot.in/
Posted by at No comments:
Labels: , , , ,
Location: New York, NY, USA

Wednesday, 18 December 2013

Prenatal And New-Born Genetic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Pharmaceuticals copy
Prenatal diagnosis or prenatal testing is performed for checking the diseases in a fetus or embryo before it is born. Although most of pregnancies end giving birth to a healthy baby but there remains chances where a child patient is born with defects.  Hence, the primary aim of the test refers to the detection of birth defects such as Down syndrome, chromosomal abnormalities, neural tube defects and genetic diseases.  In addition, diseases such as sickle cell anemia, thalassemia, cystic fibrosis are others are also identified using prenatal diagnosis. Sometimes tests are done to determine high risk pregnancies early so that a delivery can be scheduled accordingly. Presently, prenatal testing is also performed for determining the characteristics generally not related to birth defects.  Prenatal diagnosis is performed primarily for two reasons that include timely execution of medical or surgical treatment and to give parents the chance for abortion at an early stage. For, instance an ultrasound performed at 18 to 20 days of pregnancy can detect many physical changes.
Blood tests are done for performing new born screening. Through new born screening many disorders can be treated at an early stage.  Level of phenylketonuria is (PKU) is checked through blood test. PKU is a genetic disorder that is caused by the mutation in the gene for hepatic enzyme that is necessary to metabolize the amino acids. Hence if PKU is left untreated then it might cause mental impairment. Moreover, thyroid level is also checked, because hypothyroidism leads to disability in the growth. Down’s syndrome is a commonly occurring genetic disease that can be identified through prenatal testing. Amniocentesis or chorionic villus sampling is performed to examine the number of chromosomes.
Prenatal testing and newborn screening market is witnessing a considerable rise owing to rise in genetic disorders. Early diagnosis can avoid the complications with the help of prompt treatment. However, there are disparities related to the tests that are restraining the growth of this market. Major players capturing the market space include Genzyme Genetics, Biogen, Ferring Pharmaceuticals, Novartis AG and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted by at No comments:
Labels: , , ,

Monday, 16 December 2013

Drugs Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Pharmaceuticals copy
Drug testing business is described as providing of drug testing services to the various private and government agencies. Drugs testing services are primarily required for screening devices, defensive tools and for legal requirement. Drug testing is gaining importance in various parts of the world due to year on year rising instances of drug abuse among employees, students and athletes. Annually, millions of samples are tested for the presence of drug metabolites and alcohol. Moreover, drug testing agencies play an important role in indentifying drug addicts and providing solutions to help them quit the habit.
In order to create a safe and productive work environment, various multinational companies now prefer to perform employee drug testing. This also helps to reduce crime associated with drug abuse, productivity loss, serious health problems and social dysfunction.
Companies have also come to realize the various business opportunities behind drug testing. In the US alone, drug abuse cost more than $550 billion a year, which includes drug abuse and addiction due to tobacco, alcohol and illegal drugs. Moreover, illicit drug use in the region cost around $180 billion to health care system and drug enforcement agencies. On the other hand, due to globalization, drug abuse has become a worldwide problem and developing countries in Asia and Africa are now reporting more problems of drug abuse; such regions hold immense business potential for drug testing service companies.
Some of the major companies operational in this industry are Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, Dako, DiaSorin, Eiken and Fujirebio.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted by at No comments:
Labels: , , , ,

Wednesday, 11 December 2013

Pneumonia Drugs & Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Transparency Market Research
Pneumonia is a common lung infection caused by a variety of microorganisms such as bacteria, virus, fungi and parasites. In pneumonia the air sacs of lungs that are known as alveoli are filled with fluid or pus causing inflammation. The common symptoms of pneumonia are cough with phlegm, sneezing, sore throat, chills, fever and trouble in breathing. Pneumonia is usually a mild disease but under certain situations can be lethal. Children, elderly people and those with recent viral infections, lung disease and heart disease are at higher risk of developing pneumonia compared to general population. Pneumonia is of different types depending on the way it has been acquired by people such community acquired pneumonia (CAP), hospital acquired pneumonia (HAP) and healthcare associated pneumonia as patient may also develop pneumonia during their visits to other healthcare setting such as nursing homes, dialysis centers and outpatient clinics. Others are aspiration pneumonia and atypical pneumonia. Pneumonia is one of the most common hospital acquired infection.
The global market for pneumonia is segmented broadly into treatment drugs and prevention vaccines market. Usually antibiotics used to treat pneumonia include cephalosporins, penicillin, tetracyclines, fluoroquinolones, amoxicillin, clavulanic acid and vancomycin. Earlier, penicillin was widely used to treat pneumonia caused by bacteria pnemococcal pneumonia but due to wide spread use of broad spectrum antibiotics has resulted into significant drug resistance. Penicillin is still used but only after confirming the sensitivity of the bacteria towards this antibiotic. Pneumococcal conjugate vaccine such as PCV13 and pneumococcal polysaccharide vaccines such as PPV23 and Pneumovax are used to prevent pneumococcal diseases. The major players operating in this market are Sanofi, Eli Lilly, AstraZeneca, Merck & Co. Novartis, GlaxoSmithCline, Pfizer and Baxter International Inc.
The market for pneumonia drugs and vaccines is expected to grow under the impact of drivers such as increasing aging population as aging population are more susceptible to developing pneumonia and increasing prevalence of pneumonia among children. According to WHO, every year approximately 1.2 million children under the age of five years die because of pneumonia. WHO also reports only 30% of children suffering from pneumonia get required antibiotics for the treatment of pneumonia. This disease is most prevalent in South Asia and African countries.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. 
Geographies analyzed under this research report include 
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Tel: +1-518-618-1030

 Browse Market Research Blog:
Posted by at No comments:
Labels: , , ,

Tuesday, 3 December 2013

Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Pharmaceuticals copy
According to the World Health Organization (WHO), pharmacovigilance is defined as a series of actions performed to assess, detect and prevent any possible adverse effects of pharmaceutical products, and minimize the medication risks. It majorly focuses on the assessment of adverse drug reactions, which are lethal responses to drugs that occur at the doses used for treatment of a disease or used in the modification of physiological functioning. Medication issues such as drug overdose and drug abuse are also checked for, as they too may lead to some adverse drug reactions. Pharmacovigilance aims at ensuring optimum patient care and safety with respect to the usage of medications and also provides reliable information about efficient evaluation of the possible hazard and benefit profile of drugs.
The WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, (UMC), in Sweden promotes pharmacovigilance at a country level. By the end of the year 2010, 134 countries had adopted the WHO pharmacovigilance programme. The information received from healthcare professionals, patients and medical literature prove to be necessary for conducting pharmacovigilance studies.
The market for pharmacovigilance has a huge demand as all pharmaceutical license holders need to understand and comply with its guidelines. This market can be segmented based on the different technologies including drug safety database systems, signal detection systems and others. Regulatory guidelines for the same are stated by the U.S. FDA, EMA and other regulatory bodies. These regulations and guidelines provide a framework for the companies to follow in order to carry out pharmacovigilance activities.
The major factors driving growth of this market are need for efficient drugs, continuous technological upgradations, increased focus on patient care and patient safety, and intensification of safety regulations by various regulatory bodies. These factors boost the uptake of pharmacovigilance systems by pharmaceutical companies. Reluctance of companies towards adoption of new technologies, lack of proper education and training to the resources, and lack of awareness about prevailing pharmacovigilance systems might hamper the growth of the market. Currently, majority of the companies are outsourcing their pharmacovigilance operations for the purpose of cost effectiveness. The scope of these systems can be further enhanced by integrating them with other data sources such as clinical databases and medical records. These advanced and novel approaches further enhance the decision making on safety and efficacy of drugs, and provide relevant and reliable information.
This research report analyzes this market depending on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted by at No comments:
Labels: , , , ,

Pediatric Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Transparency Market Research
Pediatric drugs are a special class of drugs which are prescribed to children and infants for different diseases.  These drugs are recommended in various conditions such as asthma, anorexia, birth defects, cancer in children, growth deficiencies, juvenile diabetes, attention deficit hyperactivity disorder, and others. Various acts have been passed to control pediatric drugs such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA). These acts have been introduced to increase the investments on R&D for pediatric drugs and to increase the drugs count prescribed for children and infants.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/pediatric-drugs-market.html

Pediatric drugs are categorized in three segments namely pediatric clinical pharmacology, pediatric pharmacotherapy and pediatric pharmacy. Pediatric pharmacotherapy focuses on those drugs which will behave differently in children and adults. Pediatric clinical pharmacology includes those drugs which are helpful for mental and physical growth. Pediatric pharmacy includes all those drugs which are specifically meant for children. To treat various disease conditions different drugs are prescribed such as acetaminophen, fentanyl, ibuprofen, naloxone and methadone are given as analgesics. In addition, cefazolin, ampicillin and meropenem are prescribed to treat microbial infections whereas clonidine and etomidate are recommended for sedative effect. Various other drugs are tramadole, oxycodone, codeine, lorazepam and gabapentin.

Growing concerns globally, amongst parents has assisted the growth of this segment. Moreover, governments worldwide are funding and initiating various national programs to support use of drugs to curb infant and child mortality rates. Rise in disposable income along with awareness in people has augmented the growth of pediatric drugs in developed nations such as U.S. and Europe. In addition, rising incidence of disease conditions such as obesity, diabetes and hypertension in children have also contributed in its growth. Despite various developments, low disposable income and unawareness in developing nations are hindering the growth of this market. Moreover, side effects such as anxiety, headache and fatigue are also restricting its growth.

Some of the major market players of pediatric drug include InfaCare Inc., Medeira Therapeutics, Crucell Biologics Inc., Actelion Pharma ceuticals Ltd. and other significant players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. 

Geographies analyzed under this research report include 
·         North America 
·         Asia Pacific 
·         Europe
·         Rest of the World  

This report provides comprehensive analysis of 
·         Market growth drivers 
·         Factors limiting market growth
·         Current market trends 
·         Market structure
·         Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports On Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Download PDF File: PediatricDrugs Market - Global Industry Analysis, Size, Share, Growth, Trends AndForecast, 2013 – 2019

Contact Us

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Browse Market Research Blog:
http://tmrmarkets.blogspot.com/
http://businessindustryresearch.wordpress.com
Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)